Linezolid
Kathryn Dzintars, Pharm.D., BCPS
,
Paul A. Pham, Pharm.D.
Pediatric Dosing Author:
Alice Jenh Hsu, PharmD, BCPS, AQ-ID
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Pneumonia, hospital-acquired
caused by
MRSA
,
MSSA
, and
S. pneumoniae
.
Generally reserved for
MRSA
.
Community acquired pneumonia
caused by
S. pneumoniae
and
MSSA
.
Not a preferred agent for CAP.
Infections due to vancomycin-resistant
Enterococcus faecium
(VRE), with or without concurrent bacteremia.
Complicated and uncomplicated skin and skin structure infection including
diabetic foot ulcers
(without osteomyelitis).
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Vascular catheter associated sepsis
Surgical wound infections
Furuncle/carbuncle
Cellulitis/erysipelas
Osteomyelitis, acute
(second-line agent)
Osteomyelitis, chronic
(second-line agent)
Septic arthritis, community-acquired
(limited data)
Hardware associated septic arthritis
(limited data)
Tuberculosis
Non-tubercular mycobacteria
Nocardia
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved